0 items USD 0.00Search
- Did you mean
- endothelial carcinoma
Your search for "urothelial carcinoma" gave back 346 results.
The global Nasopharyngeal Carcinoma Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
May 2023
Price: USD 3,480.00
Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Hepatocellular Carcinoma Treatment Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
March 2023
Price: USD 4,480.00
According to our publisher latest study, the global Hepatocellular Carcinoma Treatment Drug market size was valued at USD million in 2022 and is...
Catalog:
GIR
March 2023
Price: USD 3,480.00
The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year,...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Highlights The global Renal Cell Carcinoma Clinical Trial Pipeline market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Colon & Rectal Carcinoma market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Head and neck squamous cell carcinoma is the sixth leading cancer worldwide by incidence. Head and neck squamous cell carcinoma progresses from the...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Unresectable Hepatocellular Carcinoma Treatment market...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Highlights The global Neuroendocrine Carcinoma Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
